Novavax
NVAX
#5377
Rank
S$1.82 B
Marketcap
S$11.25
Share price
-6.30%
Change (1 day)
-5.37%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): S$0.50 Billion

According to Novavax's latest financial reports the company's current earnings are S$1.02 Billion. In 2024 the company made an earning of -S$0.2 Billion, an increase over its 2023 earnings that were of -S$0.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.50 B-353.56%
2024 -S$0.2 Billion-70.39%
2023 -S$0.68 Billion-16.59%
2022 -S$0.81 Billion-62.58%
2021 -S$2.16 Billion320.54%
2020 -S$0.52 Billion234.22%
2019 -S$0.16 Billion-30.17%
2018 -S$0.22 Billion1.69%
2017 -S$0.22 Billion-36.44%
2016 -S$0.34 Billion70.4%
2015 -S$0.2 Billion89.27%
2014 -S$0.11 Billion59.83%
2013 -S$65.9 Million81.9%
2012 -S$36.23 Million50.33%
2011 -S$24.1 Million
2009 -S$47.56 Million8.8%
2008 -S$43.71 Million18.01%
2007 -S$37.04 Million18.33%
2006 -S$31.31 Million168.31%
2005 -S$11.67 Million-62.51%
2004 -S$31.13 Million52.4%
2003 -S$20.43 Million-28.21%
2002 -S$28.45 Million
2000 -S$16.21 Million177%
1999 -S$5.86 Million-11.54%
1998 -S$6.62 Million10.64%
1997 -S$5.98 Million-9.62%
1996 -S$6.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.88 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.07 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.65 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$11.85 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.33 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.28 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.34 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.42 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA